![Gustav Gaudernack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Gaudernack
Plus aucun poste en cours
Health Technology
Profil
Gustav Gaudernack is the founder of Circio Holding ASA, which was founded in 2010.
Currently, he is the Chief Scientific Officer at Ultimovacs ASA. Previously, he worked as a Professor at Norwegian Radium Hospital from 1995 to 2011.
Anciens postes connus de Gustav Gaudernack
| Sociétés | Poste | Fin |
|---|---|---|
Norwegian Radium Hospital | Corporate Officer/Principal | 01/01/2011 |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Directeur Technique/Scientifique/R&D | - |
| CIRCIO HOLDING ASA | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Norwegian Radium Hospital |
